Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 149, pseudogene (RNU1-149P) is a member of the U1 small nuclear RNA (snRNA) pseudogene family, annotated as a non-coding RNA locus. Pseudogenes like RNU1-149P bear sequence similarity to the canonical U1 snRNA, which is an essential part of the spliceosome complex responsible for pre-mRNA splicing[1][5]. Unlike functional U1 snRNA genes, pseudogenes typically possess mutations that prevent them from encoding a fully functional RNA or contributing directly to canonical spliceosomal activity[5]. However, research indicates that some U1 snRNA pseudogenes can be transcribed and incorporated into ribonucleoprotein complexes, potentially exerting regulatory effects on gene expression and mRNA processing in a cell- or stage-specific manner[5]. There is no current evidence that RNU1-149P has direct therapeutic relevance or is a target for pharmacological modulation. Its classification as a pseudogene means it is generally not considered a therapeutic target, receptor, enzyme, transporter, or similar actionable molecule[1][5].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 149, pseudogene (RNU1-149P).